Teva sees publication of decision, report in Copaxone dominance-abuse case
MLex Summary: The European Commission today released a summary version of its decision last year to fine Teva Pharmaceuticals more than 462 million euros for abusing the patent system to protect...To view the full article, register now.
Already a subscriber? Click here to view full article